Treatment of acute ischemic stroke: intravenous and endovascular therapies

References

• Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat. Rep.56(10), 1–120 (2008).
   PubMedGoogle Scholar
• Barnaby W. Stroke intervention. Emerg. Med. Clin. North Am.8, 267–281 (1990).
   PubMedGoogle Scholar
• Dobbin B. The economic impact of stroke. Neurology45(Suppl. 1), S10–S14 (1995).
   Google Scholar
• Feussner JR, Matchar DB. When and how to study the carotids. Ann. Intern. Med.109, 805–818 (1988).
   PubMedGoogle Scholar
• Zeumer H, Freitag HJ, Knospe V. Intravascular thrombolysis in central nervous system cerebrovascular disease. Neurol. Clin. North Am.2, 359–369 (1992).
   Google Scholar
• Baron J. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc. Dis.9(4), 193–201 (1999).
   PubMed Web of Science ®Google Scholar
• Heiss WD, Thiel A, Grond M, Graf R. Which targets are relevant for therapy of acute ischemic stroke? Stroke30(7), 1486–1489 (1999).
   PubMed Web of Science ®Google Scholar
• Nagesh V, Welch KM, Windham JP et al. Time course of ADCw changes in ischemic stroke: beyond the human eye! Stroke29(9), 1778–1782 (1998).
   PubMedGoogle Scholar
• Hacke W, Stingele R, Steiner T et al. Critical care of acute ischemic stroke. Intensive Care Med.21, 856–862 (1995).
   PubMedGoogle Scholar
• Astrup J, Siesjo B, Symon L. Thresholds in cerebral ischemia – the ischemic penumbra. Stroke12, 723–725 (1981).
   PubMed Web of Science ®Google Scholar
• The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med.333, 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst. Rev.3, CD000213 (2003).
   Google Scholar
• Mielke O, Wardlaw J, Liu M. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke. Cochrane Database Syst. Rev.4, CD000514 (2004).
   Google Scholar
• Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial – Europe study group. N. Engl. J. Med.335(3), 145–150 (1996).
   PubMed Web of Science ®Google Scholar
• Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial–Italy (MAST-I) group. Lancet346(8989), 1509–1514 (1995).
   PubMed Web of Science ®Google Scholar
• Donnan GA, Davis SM, Chambers BR et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) trial study group. JAMA276(12), 961–966 (1996).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA274(13), 1017–1025 (1995).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet352(9136), 1245–1251 (1998).
   PubMed Web of Science ®Google Scholar
• Clark WM, Wissman S, Albers GW et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA282(21), 2019–2026 (1999).
   PubMed Web of Science ®Google Scholar
• Tillet WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J. Exp. Med.58, 485–502 (1933).
   PubMedGoogle Scholar
• Morris AD, Ritchie C, Grosset DG et al. A pilot study of streptokinase for acute cerebral infarction. QJM88, 727–731 (1995).
   PubMedGoogle Scholar
• Cornu C, Boutitie F, Candelise L et al. Streptokinase in acute ischemic stroke: an individual patient data metaanalysis: The Thrombolysis in Acute Stroke Pooling Project. Stroke31, 1555–1560 (2000).
   PubMedGoogle Scholar
• Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischemic stroke. Cochrane Database Syst. Rev.3 (2000).
   Google Scholar
• Practice advisory: thrombolytic therapy for acute ischemic stroke–summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology47(3), 835–839 (1996).
   PubMed Web of Science ®Google Scholar
• Kwiatkowski TG, Libman R, Frankel M et al. The NINDS rt-PA Stroke Study: sustained benefit at one year. Stroke29, 288 (1998).
   Google Scholar
• Kwiatkowski TG, Libman RB, Frankel M et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N. Engl. J. Med.340(23), 1781–1787 (1999).
   PubMed Web of Science ®Google Scholar
• Broderick JP. Recanalization therapies for acute ischemic stroke. Semin. Neurol.18(4), 471–484 (1998).
   PubMed Web of Science ®Google Scholar
• The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke28, 2109–2118 (1997).
   PubMed Web of Science ®Google Scholar
• Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke28(11), 2119–2125 (1997).
   PubMed Web of Science ®Google Scholar
• Libman RB, Wirkowski E, Alvir J, Rao TH. Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. Arch. Neurol.52(11), 1119–1122 (1995).
   PubMed Web of Science ®Google Scholar
• Albers GW, Bates VE, Clark WM et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA283(9), 1145–1150 (2000).
   PubMed Web of Science ®Google Scholar
• Katzan IL, Furlan AJ, Lloyd LE et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA283(9), 1151–1158 (2000).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med.359(13), 1317–1329 (2008).
   PubMed Web of Science ®Google Scholar
• Marler JR, Tilley BC, Lu M et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke study. Neurology55(11), 1649–1655 (2000).
   PubMed Web of Science ®Google Scholar
• Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke trials. Lancet363(9411), 768–774 (2004).
   PubMed Web of Science ®Google Scholar
• Tanswell P, Modi N, Combs D, Danays T. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin. Pharmacokinet.41(15), 1229–1245 (2002).
   PubMed Web of Science ®Google Scholar
• Haley EC, Jr., Lyden PD, Johnston KC, Hemmen TM. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke36(3), 607–612 (2005).
   PubMed Web of Science ®Google Scholar
• Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke36(10), 2311–2320 (2005).
   PubMed Web of Science ®Google Scholar
• Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke36(1), 66–73 (2005).
   PubMed Web of Science ®Google Scholar
• Furlan AJ, Eyding D, Albers GW et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke37(5), 1227–1231 (2006).
   PubMed Web of Science ®Google Scholar
• Hacke W, Furlan AJ, Al-Rawi Y et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol.8(2), 141–150 (2009).
   PubMed Web of Science ®Google Scholar
• Martinez-Sanchez P, Diez-Tejedor E, Fuentes B, Ortega-Casarrubios MA, Hacke W. Systemic reperfusion therapy in acute ischemic stroke. Cerebrovasc. Dis.24(Suppl. 1), 143–152 (2007).
   PubMedGoogle Scholar
• Kohrmann M, Juttler E, Fiebach JB et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol.5(8), 661–667 (2006).
   PubMedGoogle Scholar
• Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol.7(4), 299–309 (2008).
   PubMed Web of Science ®Google Scholar
• Albers GW, Thijs VN, Wechsler L et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann. Neurol.60(5), 508–517 (2006).
   PubMed Web of Science ®Google Scholar
• Zeumer H, Hacke W, Ringelstein EF. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am. J. Neuroradiol.4, 401–404 (1983).
   PubMed Web of Science ®Google Scholar
• Zeumer H, Hundgen R, Ferbert A, Ringelstein EB. Local intraarterial fibrinolytic therapy in inaccessible internal carotid occlusion. Neuroradiology26, 315–317 (1984).
   PubMedGoogle Scholar
• Zeumer H, Freitag HJ, Zanella F et al. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-tPA). Neuroradiology35, 159–162 (1993).
   PubMed Web of Science ®Google Scholar
• Jansen O, von Kummer R, Forsting M, Hacke W, Sartor K. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am. J. Neuroradiol.16, 1977–1986 (1995).
   PubMed Web of Science ®Google Scholar
• Theron J, Courtheoux P, Casasco A et al. Local intraarterial fibrinolysis in the carotid territory. AJNR Am. J. Neuroradiol.10, 753–765 (1989).
   PubMedGoogle Scholar
• Barr JD, Mathis JM, Wildenhain SL et al. Acute stroke intervention with intraarterial urokinase infusion. J. Vasc. Interv. Radiol.5(5), 705–713 (1994).
   PubMedGoogle Scholar
• del Zoppo GJ, Ferbert A, Otis S et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke19, 307–313 (1988).
   PubMed Web of Science ®Google Scholar
• Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke19, 802–812 (1988).
   PubMed Web of Science ®Google Scholar
• Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intraarterial therapy improves outcome in patients with acute vertebrobasilar disease. Stroke19, 1216–1222 (1988).
   PubMed Web of Science ®Google Scholar
• Ezura M, Kagawa S. Selective and superselective infusion of urokinase for embolic stroke. Surg. Neurol.38, 353–358 (1992).
   PubMedGoogle Scholar
• Barnwell SL, Clark WM, Nguyen TT et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am. J. Neuroradiol.15(10), 1817–1822 (1994).
   PubMed Web of Science ®Google Scholar
• Brandt T, von Kummer R, Müller-Küppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke27(5), 875–881 (1996).
   PubMed Web of Science ®Google Scholar
• Becker KJ, Monsein LH, Ulatowski J et al. Intraarterial thrombolysis in vertebrobasilar occlusion. AJNR Am. J. Neuroradiol17(2), 255–262 (1996).
   PubMed Web of Science ®Google Scholar
• Ueda T, Sakaki S, Kumon Y, Ohta S. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke30(11), 2360–2365 (1999).
   PubMedGoogle Scholar
• Jahan R, Duckwiler GR, Kidwell CS et al. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am. J. Neuroradiol20(7), 1291–1299 (1999).
   PubMed Web of Science ®Google Scholar
• Suarez JI, Sunshine JL, Tarr R et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke30(10), 2094–2100 (1999).
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Hayakawa T, Kiuchi H. Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc. Dis.3(4), 269–272 (1993).
   Web of Science ®Google Scholar
• Wolpert SM, Bruckmann H, Greenlee R et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am. J. Neuroradiol.14, 3–13 (1993).
   PubMedGoogle Scholar
• Mori E, Yoneda Y, Tabuchi M et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology42(5), 976–982 (1992).
   PubMed Web of Science ®Google Scholar
• del ZG, Higashida RT, Furlan AJ et al. PROACT: a Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke29(1), 4–11 (1998).
   PubMed Web of Science ®Google Scholar
• Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA282(21), 2003–2011 (1999).
   PubMed Web of Science ®Google Scholar
• Zeumer H, Freitag HJ, Grzyska U, Neunzig HP. Local intraarterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology31(4), 336–340 (1989).
   PubMed Web of Science ®Google Scholar
• Rosa A, Gautier J. Thrombolytic agents in cerebral infarctions. Rev. Neurol.147, 99–110 (1991).
   PubMedGoogle Scholar
• Kubic C, Adams R. Occlusion of the basilar artery: a clinical and pathological study. Brain69, 73–121 (1946).
   PubMed Web of Science ®Google Scholar
• Archer CR, Horenstein S. Basilar artery occlusion: clinical and radiological correlation. Stroke8(3), 383–390 (1977).
   PubMed Web of Science ®Google Scholar
• Ferbert A, Bruckmann H, Drummen R. Clinical features of proven basilar artery occlusion. Stroke21(8), 1135–1142 (1990).
   PubMed Web of Science ®Google Scholar
• Bogousslavsky J, Regli F, Maeder P, Meuli R, Nader J. The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography. Neurology43(8), 1528–1533 (1993).
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in stroke: possibilities and hazards. Stroke17(4), 595–607 (1986).
   PubMed Web of Science ®Google Scholar
• Mitchell PJ, Gerraty RP, Donnan GA et al. Thrombolysis in the vertebrobasilar circulation: the Australian urokinase stroke trial – a pilot study. Cerebrovasc. Dis.7(2), 94–99 (1997).
   Google Scholar
• Macleod MR, Davis SM, Mitchell PJ et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc. Dis.20(1), 12–17 (2005).
   PubMed Web of Science ®Google Scholar
• Lewandowski CA, Frankel M, Tomsick TA et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke30(12), 2598–2605 (1999).
   PubMed Web of Science ®Google Scholar
• Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke35(4), 904–911 (2004).
   PubMed Web of Science ®Google Scholar
• The Interventional Management of Stroke (IMS) II Study. Stroke38(7), 2127–2135 (2007).
   PubMed Web of Science ®Google Scholar
• Weaver WD, Simes RJ, Betriu A et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA278(23), 2093–2098 (1997).
   PubMed Web of Science ®Google Scholar
• Balousek PA, Knowles HJ, Higashida RT, del Zoppo GJ. New interventions in cerebrovascular disease: the role of thrombolytic therapy and balloon angioplasty. Curr. Opin. Cardiol.11(5), 550–557 (1996).
   PubMed Web of Science ®Google Scholar
• Bücker A, Schmitz-Rode T, Vorwerk D, Günther RW. Comparative in vitro study of two percutaneous hydrodynamic thrombectomy systems. J. Vasc. Interv. Radiol.7(3), 445–449 (1996).
   PubMed Web of Science ®Google Scholar
• Martinez H, Zoarski GH, Obuchowski AM et al. Mechanical thrombectomy of the internal carotid artery and middle cerebral arteries for acute stroke by using the retriever device. AJNR Am. J. Neuroradiol.25(10), 1812–1815 (2004).
   PubMed Web of Science ®Google Scholar
• Gobin YP, Starkman S, Duckwiler GR et al. MERCI 1: a Phase I study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke35(12), 2848–2854 (2004).
   PubMed Web of Science ®Google Scholar
• Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am. J. Neuroradiol.27(6), 1177–1182 (2006).
   PubMed Web of Science ®Google Scholar
• Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke39(4), 1205–1212 (2008).
   PubMed Web of Science ®Google Scholar
• Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke36(7), 1432–1438 (2005).
   PubMed Web of Science ®Google Scholar
• Saver JL. Does the Merci Retriever work? For. Stroke37(5), 1340–1341 (2006).
   PubMedGoogle Scholar
• Wechsler LR. Does the Merci Retriever work? Against. Stroke37(5), 1341–1342 (2006).
   PubMedGoogle Scholar
• Becker KJ, Brott TG. Approval of the MERCI clot retriever: a critical view. Stroke36(2), 400–403 (2005).
   PubMed Web of Science ®Google Scholar
• Bose A, Henkes H, Alfke K et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am. J. Neuroradiol.29(7), 1409–1413 (2008).
   PubMed Web of Science ®Google Scholar
• Clinical data from the pivotal Penumbra Stroke trial. Presented at: International Stroke Conference 2008. New Orleans, LA, USA, 20–22 February 2008.
   Google Scholar
• Broderick JP. Endovascular therapy for acute ischemic stroke. Stroke40(Suppl. 3), S103–S106 (2008).
   Google Scholar